PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Reference-Cited by-同舟云学术

PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

Published:2014-11-21 Issue:3 Volume:62 Page:427-433
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Henriksen Louise Tram¹,Harila-Saari Arja²,Ruud Ellen³,Abrahamsson Jonas⁴,Pruunsild Kaie⁵,Vaitkeviciene Goda⁶,Jónsson Ólafur Gísli⁷,Schmiegelow Kjeld⁸⁹,Heyman Mats²,Schrøder Henrik¹,Albertsen Birgitte Klug¹,

Affiliation:

1. Department of Pediatrics; Aarhus University Hospital; Aarhus Denmark

2. Department of Woman and Child Health; Karolinska Institute; Stockholm Sweden

3. Department of Pediatric Medicines; Oslo University Hospital; Rikshospitalet Oslo Norway

4. Department of Clinical Sciences; Queen Silviás Childreńs Hospital; Gothenburg Sweden

5. Department of Oncology and Hematology; Tallinn Childreńs Hospital; Tallinn Estonia

6. Faculty of Medicine; Clinic of Childreńs Diseases; Vilnius University; Vilnius Lithuania

7. Pediatric Hematology-Oncology; Childreńs Hospital; Reykjavik Iceland

8. Department of Pediatric and Adolescent Medicine; Copenhagen University Hospital; Copenhagen Denmark

9. Faculty of Medicine; Institute of Clinical Medicine; University of Copenhagen; Copenhagen Denmark

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference27 articles.

1. Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01;Silverman;Blood,2001

2. Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients;Wang;Leukemia,2003

3. Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia;Woo;J Clin Oncol,2000

4. Anaphylactoid reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma;Evans;Cancer,1982

5. A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial;Journal of Clinical Oncology;2024-02-02

2. Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia;Leukemia;2024-01-29

3. Chemotherapy‐related toxicities follow a typical pattern in children treated for acute lymphoblastic leukaemia;Acta Paediatrica;2024-01-04

4. Increase in PEG-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia;2023-11-30

5. A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition;Malaysian Journal of Medical Sciences;2023-10-30